Written by Erik Malmstrom, CEO of SafeTraces
In an April 14 New York Times article titled “Stay 6 Feet Apart, We’re Told. But How Far Can Air Carry the Coronavirus,” Dr. Michael Osterholm, Director of the Center for Infectious Disease Research and Policy at the University of Minnesota, posed a question with enormous implications for global health and safety as we return to shared spaces in the absence of a vaccine and reliable rapid testing:
“The question is what does it take for you to get infected? And that I think is the trillion-dollar question we have…maybe all it takes is an aerosol. You don’t need any droplets at all.”
Dr. Osterholm highlights one of the critical “known unknowns” of COVID-19 – the transmission role of aerosols, or particles under five microns in diameter that are emitted while talking and breathing, that can stay suspended in air for hours, and that can travel over 20 feet.
Currently, guidance from the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) of six feet separation in public assumes that large droplets from coughing and sneezing are the principal means of COVID-19 transmission and that most large droplets drop to the ground within six feet.
However, a chorus of prominent experts have emphasized the role of aerosols and air flow as a potentially important transmission vehicle for COVID-19, with emerging scientific research lending credence to their argument:
What does the potential for airborne transmission of COVID-19 via aerosols mean for the air that we breathe in shared spaces that many of us will be returning to?
On this matter, the American Society of Heating, Refrigerating, and Air-Conditioning Engineers (ASHRAE), a leading professional association whose guidance is widely referred to by facility managers, published a position document on infectious aerosols in April stating:
“Transmission of SARS-CoV-2 through the air is sufficiently likely that airborne exposure to the virus should be controlled. Changes in building operations, including the operation of heating, ventilating, and air-conditioning systems, can reduce airborne exposures.”
Given the complexity, urgency, and our evolving understanding of the risk presented by COVID-19 aerosols, practical application of ASHRAE’s guidance is easier said than done. In our experience, the airborne transmission risk is not always well-understood by facility managers and therefore insufficiently accounted for in reopening plans. Moreover, there is a notable gap in diagnostic tools available for assessing the risk of airborne transmission of COVID-19 indoors.
Based on groundbreaking technology developed with the support of the National Institutes of Health (NIH), our veriDART solution for verifying safe indoor airflows fills this gap. veriDART leverages proprietary airborne tracers that safely mimic the mobility of airborne pathogens like COVID-19 in order to identify high-risk transmission vectors, assess the efficacy of filtration, ventilation, and anti-microbial solutions, and instill public trust and confidence in buildings for safe occupancy.
Joseph Allen, Director of the Healthy Buildings program at Harvard T.H. Chan School of Public Health said, “The evidence suggests that mitigating airborne transmission should be at the front of our disease-control strategies for COVID-19.” As facility managers gradually reopen buildings while preparing for a potential second wave of viral outbreak this fall, veriDART is a powerful tool in the fight against COVID-19 – and gets us a step closer to answering the trillion-dollar question.
Please follow up to learn more and become an early adopter.